Bangalore-based Deep-tech Firm Algorithmic Biologics Obtains Undisclosed Fund from Axilor Lab
Algorithmic Biologics Pvt Ltd. (ABPL), a deep-tech firm developing algorithms for molecular programming has obtained initial investment from Axilor Lab in an undisclosed sum.
Axilor Labs is a venture curation project launched by Axilor to expedite the commercial success of revolutionary ideas addressing global health and wellness concerns. They want to help ideas get to the impactful proof-of-science level and work with inventors to develop start-ups where the effect of transformational technology may be realised economically.
ABPL's platform technology is used in healthcare, agriculture, pharmaceuticals, animal husbandry, synthetic biology, molecular, and biology food safety research as a compression algorithm for molecular testing. ABPL is collaborating with top brands in a variety of sectors to provide better molecular testing for food safety and seed R&D.
They started with their unique quick Covid testing method nine months ago and are now expanding to other diagnostic procedures. Tapestry, their device, is already providing economical Covid-19 screening on college campuses.
Axilor co-founder and Harvard Business School professor Tarun Khanna said, "Creating and curating ventures requires innate talent to come up with an idea, creativity to demonstrate product-market-fit, and operating skill to scale the effort. Throughout, we need capital. At Axilor Labs, all of these ingredients come together to bring cutting-edge scientific ideas into India's mainstream. Our investment in Algorithmic exemplifies this approach. Together with Manoj, we are helping prove the business impact of this breakthrough technology.”
Dr. Manoj Gopalkrishnan, founder and CEO of ABPL said, “we are pursuing our vision of smarter molecular testing leading to better health for all. We are deeply invested in science and technology, and are bringing cutting-edge ideas from molecular computing and computer science to molecular testing.”
Dr. Manoj Gopalkrishnan is an alumni of the University of South California and a professor at IIT Bombay. Algorithmic Biologics intends to use the cash to commercialise these applications and expand their IP portfolio to produce new molecular technology building blocks.
Axilor Labs is a venture curation project launched by Axilor to expedite the commercial success of revolutionary ideas addressing global health and wellness concerns. They want to help ideas get to the impactful proof-of-science level and work with inventors to develop start-ups where the effect of transformational technology may be realised economically.
ABPL's platform technology is used in healthcare, agriculture, pharmaceuticals, animal husbandry, synthetic biology, molecular, and biology food safety research as a compression algorithm for molecular testing. ABPL is collaborating with top brands in a variety of sectors to provide better molecular testing for food safety and seed R&D.
They started with their unique quick Covid testing method nine months ago and are now expanding to other diagnostic procedures. Tapestry, their device, is already providing economical Covid-19 screening on college campuses.
Axilor co-founder and Harvard Business School professor Tarun Khanna said, "Creating and curating ventures requires innate talent to come up with an idea, creativity to demonstrate product-market-fit, and operating skill to scale the effort. Throughout, we need capital. At Axilor Labs, all of these ingredients come together to bring cutting-edge scientific ideas into India's mainstream. Our investment in Algorithmic exemplifies this approach. Together with Manoj, we are helping prove the business impact of this breakthrough technology.”
Dr. Manoj Gopalkrishnan, founder and CEO of ABPL said, “we are pursuing our vision of smarter molecular testing leading to better health for all. We are deeply invested in science and technology, and are bringing cutting-edge ideas from molecular computing and computer science to molecular testing.”
Dr. Manoj Gopalkrishnan is an alumni of the University of South California and a professor at IIT Bombay. Algorithmic Biologics intends to use the cash to commercialise these applications and expand their IP portfolio to produce new molecular technology building blocks.
.jpg "Caim By Arelang: India's First CandyCeuticals Company Offering Nutraceuticals in Irresistibly Tasty Treats")
